1. Home
  2. ESGRP vs GENE Comparison

ESGRP vs GENE Comparison

Compare ESGRP & GENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESGRP
  • GENE
  • Stock Information
  • Founded
  • ESGRP N/A
  • GENE 1989
  • Country
  • ESGRP Bermuda
  • GENE Australia
  • Employees
  • ESGRP 805
  • GENE N/A
  • Industry
  • ESGRP Property-Casualty Insurers
  • GENE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ESGRP Finance
  • GENE Health Care
  • Exchange
  • ESGRP Nasdaq
  • GENE Nasdaq
  • Market Cap
  • ESGRP N/A
  • GENE N/A
  • IPO Year
  • ESGRP N/A
  • GENE N/A
  • Fundamental
  • Price
  • ESGRP $25.44
  • GENE $0.80
  • Analyst Decision
  • ESGRP
  • GENE
  • Analyst Count
  • ESGRP 0
  • GENE 0
  • Target Price
  • ESGRP N/A
  • GENE N/A
  • AVG Volume (30 Days)
  • ESGRP N/A
  • GENE 65.8K
  • Earning Date
  • ESGRP N/A
  • GENE 08-13-2024
  • Dividend Yield
  • ESGRP N/A
  • GENE N/A
  • EPS Growth
  • ESGRP N/A
  • GENE N/A
  • EPS
  • ESGRP N/A
  • GENE N/A
  • Revenue
  • ESGRP N/A
  • GENE $5,776,090.00
  • Revenue This Year
  • ESGRP N/A
  • GENE N/A
  • Revenue Next Year
  • ESGRP N/A
  • GENE N/A
  • P/E Ratio
  • ESGRP N/A
  • GENE N/A
  • Revenue Growth
  • ESGRP N/A
  • GENE 293.98
  • 52 Week Low
  • ESGRP N/A
  • GENE $0.90
  • 52 Week High
  • ESGRP N/A
  • GENE $4.75
  • Technical
  • Relative Strength Index (RSI)
  • ESGRP 62.69
  • GENE 16.54
  • Support Level
  • ESGRP $25.02
  • GENE $1.23
  • Resistance Level
  • ESGRP $25.25
  • GENE $1.51
  • Average True Range (ATR)
  • ESGRP 0.16
  • GENE 0.17
  • MACD
  • ESGRP 0.05
  • GENE -0.04
  • Stochastic Oscillator
  • ESGRP 98.55
  • GENE 5.00

About ESGRP Enstar Group Limited Depositary Shares Each Representing 1/1000th of an interest in Preference Shares

Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through four reportable segments: Run-off, Assumed Life, Investments, and Legacy Underwriting.

Share on Social Networks: